[Basis for the use of a new galena-based substance from plants for prevention and treatment of cholelithic disease].
With the purpose of prevention and treatment of cholelithic disease, a new galena-based phytocomposition having the choleritic, cholekinetic, spasmolytic and hypocholesterolemic effects at the same time was administered to patients along with lithotripsy. Clinical manifestations of cholecystitis disappeared after a daily intake of the phytocomposition during 30 days in 96 patients out of 418 people having the diagnosis of cholelithic disease and high initial concentrations of?-lipoproteins and cholesterol in the blood serum. The level of lipids dropped reliably, and it became much easier to use the lithotripsy method. Due to the decrease of bile viscosity, it was possible to note easier elimination of fragments from the gallbladder. During the monotherapy with the galena-based phytocomposition, full litholisis of single (up to 30 mm) or multiple (up to 50% of the gallbladder volume) calculi was determined in seven patients out of 47 (17%) during the period from two to six months.
Bogdarin
Iu A
IuA
Scientific Research Institute of Gastroenterology for Children, Russian Ministry of Health, City Hospital No. 28, Nizhni Novgorod.
Bundin
D V
DV
D000328:Adult; D002769:Cholelithiasis / Q000188:drug therapy* / Q000517:prevention & control*; D020829:Equisetum; D005260:Female; D006801:Humans; D007854:Lead / Q000627:therapeutic use*; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D018515:Plant Leaves; D028321:Plant Preparations / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D028321:Plant Preparations; D013440:Sulfides; C018391:lead sulfide; D007854:Lead